Page last updated: 2024-11-05

thiotepa and Radiation Pneumonitis

thiotepa has been researched along with Radiation Pneumonitis in 1 studies

Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).

Radiation Pneumonitis: Inflammation of the lung due to harmful effects of ionizing or non-ionizing radiation.

Research Excerpts

ExcerptRelevanceReference
"Radiation pneumonitis was observed in 5 patients (7%), 4 of whom had undergone high-dose chemotherapy (P = 0."2.68The toxicity of radiotherapy following high-dose chemotherapy with peripheral blood stem cell support in high-risk breast cancer: a preliminary analysis. ( Baars, JW; Beijnen, JH; Borger, JH; Richel, DJ; Rodenhuis, S; Rutgers, EJ; Schaake-Koning, CC; Schornagel, JH; van der Wall, E; van Zandwijk, N, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
van der Wall, E1
Schaake-Koning, CC1
van Zandwijk, N1
Baars, JW1
Schornagel, JH1
Richel, DJ1
Rutgers, EJ1
Borger, JH1
Beijnen, JH1
Rodenhuis, S1

Trials

1 trial available for thiotepa and Radiation Pneumonitis

ArticleYear
The toxicity of radiotherapy following high-dose chemotherapy with peripheral blood stem cell support in high-risk breast cancer: a preliminary analysis.
    European journal of cancer (Oxford, England : 1990), 1996, Volume: 32A, Issue:9

    Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin

1996